治愈的背后隐藏着风险:在格雷夫斯病中,卡比马诱导的血管
Judat Tasawoor1, Mariya Manzoor2, Abir Aijaz3
1Medicine, Sub-District Hospital, Sopore, IND.
Cureus
|February 9, 2026
概括
卡比马是一种抗甲状腺药物,很少会导致血管,严重的胀反应. 早期识别和停止卡尔比马治疗对于管理这种过敏反应至关重要.
科学领域:
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
- 过敏和免疫学 过敏和免疫学
背景情况:
- 卡比马是一种常见的抗甲状腺药物治疗甲状腺功能障碍.
- 副作用通常是轻微的皮肤反应.
- 血管是一种罕见但严重的过敏反应对carbimazole.
研究的目的:
- 在开始服用卡尔比马后报告出现急性面部血管的情况.
- 强调识别对抗甲状腺药物的罕见过敏反应的重要性.
主要方法:
- 一个病人的病例报告,在开始服用卡比马后,面部血管发病.
- 临床检查和评估药物和症状之间的时间关系.
- 停止卡比马和使用抗组胺剂和皮质类固醇的管理.
主要成果:
- 患者经历了突然的周围耳道和唇部胀,并出现轻微的消化不良.
- 没有观察到呼吸道损害或疹.
- 在卡尔比马戒药后的两天内,症状完全消失.
结论:
- 卡比马可以诱导血管,这是一个罕见但显著的不良影响.
- 及时诊断,药物停用和适当的管理是至关重要的.
- 意识到这种反应可以提高抗甲状腺治疗中的患者安全性.
相关概念视频
Esophageal Varices-I: Introduction
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Aneurysm III: Interprofessional Care
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...


